We focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists and rheumatologists.
We focus on niche products and orphan medications, in areas with a high unmet need. We collaborate with diagnostic labs and partners to provide access to innovative molecular companion diagnostic products aimed at transforming patient care.
We partner, co-develop and commercialize highly differentiated assets in oncology and immunology in the South Asian markets. Our team of regulatory and medical experts structure, design and execute robust clinical studies as well as secure regulatory approvals and commercialize products with a strong science-focused approach.